Figure 1: Study design
Treatment A: administration of 50 mg qd empagliflozin for 5 days; treatment B: co-administration of 50 mg empagliflozin and 1 mg glimepiride for 1 day; treatment C: administration of 1 mg glimepiride for 1 day

Macha et al.Journal of Diabetes Research and Clinical Metabolism  2012 1:14DOI : 10.7243/2050-0866-1-14